Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Haematologica (2012) Vol. 98, Iss. 2, pp. 239-246
Open Access | Times Cited: 304

Showing 1-25 of 304 citing articles:

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Naveen Pemmaraju, Andrew A. Lane, Kendra Sweet, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 17, pp. 1628-1637
Open Access | Times Cited: 341
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Ugo Testa, Elvira Pelosi, Arthur E. Frankel
Biomarker Research (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 230
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
Arthur E. Frankel, Jung Hee Woo, Chul Ahn, et al.
Blood (2014) Vol. 124, Iss. 3, pp. 385-392
Open Access | Times Cited: 215
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Joan Montero, Jason Stephansky, Tianyu Cai, et al.
Cancer Discovery (2016) Vol. 7, Iss. 2, pp. 156-164
Open Access | Times Cited: 184
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 23
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
Maria Rosaria Sapienza, Fabio Fuligni, Claudio Agostinelli, et al.
Leukemia (2014) Vol. 28, Iss. 8, pp. 1606-1616
Open Access | Times Cited: 164
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N. Kelly, et al.
Cancer Cell (2016) Vol. 30, Iss. 5, pp. 764-778
Open Access | Times Cited: 143
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
Khaled Alayed, Keyur P. Patel, Sergej Konoplev, et al.
American Journal of Hematology (2013) Vol. 88, Iss. 12, pp. 1055-1061
Open Access | Times Cited: 133
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Ugo Testa, Elvira Pelosi, Germana Castelli
Cancers (2019) Vol. 11, Iss. 9, pp. 1358-1358
Open Access | Times Cited: 128
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
Tomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Blood (2015) Vol. 125, Iss. 23, pp. 3559-3562
Open Access | Times Cited: 124
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 110
Extramedullary Manifestations of Myeloid Neoplasms
Carla S. Wilson, L. Jeffrey Medeiros
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 2, pp. 219-239
Open Access | Times Cited: 109
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martín‐Martín, Antonio López, María‐Belén Vidriales, et al.
Oncotarget (2015) Vol. 6, Iss. 22, pp. 19204-19216
Open Access | Times Cited: 107
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek Upadhyay, et al.
Blood (2019) Vol. 134, Iss. 8, pp. 678-687
Open Access | Times Cited: 84
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y. Jen, Xin Gao, Liang Li, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 3, pp. 532-536
Open Access | Times Cited: 80
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation (2013) Vol. 19, Iss. 7, pp. 1006-1012
Open Access | Times Cited: 77
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 10174-10181
Open Access | Times Cited: 77
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases
Fabio Facchetti, Stefano Pileri, Luisa Lorenzi, et al.
Virchows Archiv (2017) Vol. 471, Iss. 4, pp. 467-489
Closed Access | Times Cited: 72
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top